Ht31 peptide inhibited inflammatory pain by blocking NMDA receptor-mediated nociceptive transmission in spinal dorsal horn of mice

Neuropharmacology. 2015 Feb:89:290-7. doi: 10.1016/j.neuropharm.2014.09.031. Epub 2014 Oct 12.

Abstract

A kinase anchoring proteins (AKAPs) assemble cAMP-dependent protein kinase (PKA) into signaling complexes with a wide range of ion channels, including N-methyl-d-aspartate (NMDA)-subtype glutamate receptor (NMDAR) that is critical for the central sensitization of nociceptive behaviors. Although PKA has been widely described in the regulation of NMDAR-dependent nociceptive transmission and plasticity, the roles of AKAPs in these processes are largely unknown as yet. The present study interfered with AKAPs/PKA interaction by introducing stearated Ht31 peptide (St-Ht31) into spinal dorsal horn neurons, and investigated the possible changes of primary afferent-evoked, NMDAR-mediated excitatory postsynaptic currents (NMDAR-EPSCs). Whole-cell patch clamp recordings demonstrated that intracellular loading of St-Ht31 through the glass pipettes didn't affect NMDAR-mediated synaptic responses in the spinal cord slices from intact mice. When inflammatory pain was established by intraplantar injection of Complete Freund's Adjuvant (CFA), however, St-Ht31 significantly repressed the amplitudes of NMDAR-EPSCs by selectively removing GluN2B subunit-containing NMDAR out of synapses. With the inhibition of NMDAR-mediated nociceptive transmission, St-Ht31 effectively ameliorated CFA-induced inflammatory pain. Pharmacological manipulation of microtubule-based NMDAR transport, dynamin-dependent NMDAR endocytosis or actin depolymerization abolished the inhibitory effects of St-Ht31 peptide on NMDAR-EPSCs, suggesting that disruption of AKAPs/PKA interaction by St-Ht31 might disturb multiple NMDAR trafficking steps to reduce the receptor synaptic expression and spinal sensitization.

Keywords: A kinase anchoring proteins; Inflammatory pain; NMDA receptor; Spinal cord; cAMP–dependent protein kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Anesthetics / therapeutic use*
  • Animals
  • Disease Models, Animal
  • Freund's Adjuvant / toxicity
  • Ganglia, Spinal / cytology*
  • In Vitro Techniques
  • Inflammation / chemically induced
  • Inflammation / complications
  • Male
  • Mice
  • Mice, Inbred Strains
  • Motor Activity / drug effects
  • Neurons / drug effects*
  • Neurons / ultrastructure
  • Pain / drug therapy*
  • Pain / etiology
  • Pain Measurement
  • Pain Threshold / drug effects
  • Proteins / therapeutic use*
  • Sensory Receptor Cells / drug effects*
  • Spinal Cord / pathology
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism

Substances

  • Anesthetics
  • Ht 31 protein, synthetic
  • Proteins
  • Freund's Adjuvant